MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one ...

Verastem's promising combination therapy for LGSOC, diverse pipeline, and strong financial position make it a speculative buy ...

Using NGS in prognostic assessments enhances myelofibrosis prognosis and survival estimates, representing a step toward personalized medicine in myelofibrosis.

Sysmex Inostics Inc., a subsidiary of Japan's Sysmex Corporation and Baltimore-based biotechnology firm and CLIA-certified lab, announced that its RAS-RAF-SEQ Laboratory Developed Test has been ...

Despite advances in therapeutic approaches, lung cancer remains the leading cause of cancer-related deaths. To understand the molecular programs underlying lung cancer initiation and maintenance, we ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

The series of a premier global route to enable elite amateur golfers to reach the highest level of competition ...

RMC-6236 is a small molecule commercialized by Revolution Medicines, with a leading Phase II program in Metastatic Colorectal Cancer.

SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for ...

Complete with buffet breakfast and a bottle of bubbly. Head to Ras Al Khaimah’s The Cove Rotana Resort for your next romantic escape. Partner Content. Hotels.